HKU Scholars Hub: Browsing DSpace

Browsing by Author Schäfer, MR

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 5 to 11 of 11 < previous

	Title	Author(s)	Issue Date	Views
	Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial Journal:Schizophrenia Research	Bolt, LK Amminger, GP Farhall, J McGorry, PD Nelson, B Markulev, C Yuen, HP Schäfer, MR Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher-Rössler, A Verma, S Thompson, A Yung, AR Allott, KA	2019	11
	Omega‐3 fatty acids and neurocognitive ability in young people at ultra‐high risk for psychosis Journal:Early Intervention in Psychiatry	McLaverty, A Allott, KA Berger, M Hester, R McGorry, PD Nelson, B Markulev, C Yuen, HP Schäfer, MR Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher‐Rössler, A Verma, S Thompson, A Yung, AR Amminger, GP	2020	12
	Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis Journal:Psychotherapy and Psychosomatics	Hartmann, JA McGorry, P Schmidt, S Amminger, P Yuen, HP Markuley, C Berger, GE Chen, EYH de Haan, L Hickie, IB Lavoie, S McHugh, MJ Mossaheb, N Nieman, DH Nordentoft, M Riecher-Rössler, A Schäfer, MR Schlögelhofer, M Smesny, S Thompson, A Verma, SK Yung, A Nelson, B	2017	105
	Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial Journal:Frontiers in Psychiatry	Berger, M Nelson, B Markulev, C Yuen, HP Schäfer, MR Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher-Rössler, A Verma, S Mitchell, TW Meyer, BJ Thompson, A Yung, AR McGorry, PD Amminger, GP	2019	13
	Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis Journal:Schizophrenia Research	Alqarni, A Mitchell, TW McGorry, PD Nelson, B Markulev, C Yuen, HP Schäfer, MR Berger, M Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH Haan, L Nieman, DH Nordentoft, M Riecher-Rössler, A Verma, S Thompson, A Yung, AR Meyer, BJ Amminger, GP	2020	40
	The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis Journal:Biological Psychiatry	Amminger, GP Nelson, B Markulev, C Yuen, HP Schäfer, MR Berger, M Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher-Rössler,, A Verma, S Thompson, A Yung, AR McGorry, PD	2020	11
	Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial Journal:Behaviour Research and Therapy	Hartmann, JA Schmidt, SJ McGorry, PD Berger, M Berger, GE Chen, EYH de Haan, L Hickie, IB Lavoie, S Markule, C Mossaheb, N Nieman, DH Nordentoft, M Polari, A Riecher-Rössler, A Schäfer, MR Schlögelhofer, M Smesny, S Thompson, A Verma, SK Yuen, HP Yung, AR Amminger, GP Nelson, B	2020

Showing results 5 to 11 of 11 < previous